Please login to the form below
contraception
This page shows the latest contraception news and features for those working in and with pharma, biotech and healthcare.
Recognising HIV Vaccine Awareness Day
By helping more individuals access vaccines and other forms of prevention such as contraception, we can solve the problem at the root and efficiently assist individuals affected by life-threatening illnesses,”
Latest news
-
Merck & Co spinoff Organon launches with the aim of 'improving health outcomes for women'
Organon is planning to go beyond offering products for contraception and fertility in a bid to ‘broaden its definition of women’s health’, to address conditions that either are unique to
-
Merck & Co reveals plans for women’s health spinoff Organon
The company will also go beyond offering products for contraception and fertility in a bid to ‘broaden its definition of women’s health’, to address conditions that either are unique to
-
Making social sexy
Diagnosis and treatment of sexually transmitted infections and diseases. Advice on (and dispensing of) emergency contraception.
-
CHMP backs Bayer’s tumour-agnostic drug Vitrakvi
Finally, the panel recommended that Novartis’ multiple sclerosis drug Gilenya (fingolimod) should not be used in pregnant women and in women able to have children who are not using effective contraception
-
'Femtech' poised to explode, with applications set to trigger healthcare disruption
The consultants say the market, which could be worth $50bn by 2025, has already seen a number of innovations, including European CE approval for the first mobile application for contraception in
More from news
Approximately 10 fully matching, plus 66 partially matching documents found.
Latest Intelligence
-
Immunisation politicised
contraception research and development.
-
The pill branding
In Eastern Europe and Belarus, the positioning rather targets the topic of escape, and in Latin American countries, the brands focus on the very neutral topic of contraception. ... Naming and branding recommendations. Drawing on a branding study we
-
Designing unique patient solutions in rare disease
She has worked across a range of therapy areas including Psoriasis, Oral Contraception and MS.
-
Pharma deals during June 2013
Bayer closed its acquisition of Conceptus, securing access to Essure, a non-surgical method of birth control, which extends Bayer's franchise in contraception.
-
Pharma deals during January 2013
This acquisition brings with it an IUD for long term contraception (pending approval in Europe and phase III in the US) and Daifert an immunoassay kit for in vitro fertilisation. ... Uteron Pharma / Watson. Acquisition. Contraception fertility. 305.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
confidence. This has allowed the app to market itself as a form of digital contraception for those looking to avoid pregnancy. ... Published September 10, 2018. Accessed November 4, 2021. Wilkinson E. NICE: More evidence needed before NHS can adopt use
-
Breaking the silence: It’s time to talk about the menopause
Vivo, a decade ago only a few key companies were considered ‘experts in the space’, whereas today more and more companies are addressing women’s health needs beyond fertility and contraception.
-
Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women's health
More than 3, 000 users per month also engage with its digital contraception counsellor Choice.
-
How femtech is changing the future of women's health
can. Femtech innovations in reproductive health, endometriosis, contraception, menopause and women’s mental health have had success in clinical trials and won millions of global supporters.
-
Is COVID-19 yet another barrier to contraceptive access?
Confusion as to whether access to contraception was considered an ‘essential’ reason for travel. ... However, making forms of contraception more readily available won’t fully solve the problem.
More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
